Clinical Trial Update: Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease

View source ↗

Summary

Verve Therapeutics reports long-term follow-up data from participants treated with its investigational gene-editing therapy for cardiovascular disease. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• VERVE-101

Snippet

Sponsor: Verve Therapeutics, Inc. | Conditions: Atherosclerotic Cardiovascular Disease, Heterozygous Familial Hypercholesterolemia | Status: ENROLLING_BY_INVITATION